A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors
HiFiBiO Therapeutics
HiFiBiO Therapeutics
Seattle Children's Hospital
Seattle Children's Hospital
Instituto do Cancer do Estado de São Paulo